Cardiovascular Prostheses
AssigneeCorMatrix Cardiovascular, Inc.
InventorRobert G Matheny
Life of this patent
Estimating the term…
Abstract
Cardiovascular prostheses for treating, reconstructing and replacing damaged or diseased cardiovascular tissue. The prostheses are in the form of sheet structures that are formed from a composition that includes adolescent mammalian dermal tissue and a plurality of exogenously added exosomes. In some instances, the composition also includes at least one exogenously added cell, such as an embryonic stem cell, a mesenchymal stem cell and a hematopoietic stem cell. The prostheses are adapted to induce neovascularization, stem cell proliferation and, thereby, remodeling of damaged biological tissue and regeneration of new biological tissue and structures, when the prostheses are delivered to the damaged biological tissue.
Claims6
A prosthesis for treating damaged biological tissue, comprising:
- a sheet structure comprising an exosome augmented extracellular matrix (ECM) composition, said exosome augmented ECM composition comprising adolescent mammalian dermal tissue, a plurality of exogenously added exosomes and at least one exogenously added cell selected from the group consisting of an embryonic stem cell, a mesenchymal stem cell and a hematopoietic stem cell,
- said adolescent mammalian dermal tissue comprising acellular ECM, endogenous collagen type I, collagen type III, proteoglycans, and at least one growth factor selected from the group consisting of transforming growth factor beta (TGF-β) and fibroblast growth factor-2 (FGF-2),
- said sheet structure, when delivered to damaged biological tissue, being adapted to induce neovascularization, stem cell proliferation and, thereby, remodeling of said damaged biological tissue and regeneration of new biological tissue and structures.
A prosthesis for treating damaged biological tissue, comprising:
- a sheet structure comprising an exosome augmented extracellular matrix (ECM) composition, said exosome augmented ECM composition comprising adolescent mammalian dermal tissue and a plurality of exogenously added exosomes, each of said plurality of exogenously added exosomes encapsulating a nucleic acid selected from the group consisting of DNA, RNA, and micro-RNA (miRNA),
- said adolescent mammalian dermal tissue comprising acellular ECM, endogenous collagen type I, collagen type III, proteoglycans, and at least one growth factor selected from the group consisting of transforming growth factor beta (TGF-β) and fibroblast growth factor-2 (FGF-2),
- said sheet structure, when delivered to damaged biological tissue, being adapted to induce neovascularization, stem cell proliferation and, thereby, remodeling of said damaged biological tissue and regeneration of new biological tissue and structures.
Dependencies are inferred from the claim text.